Reuters logo
BRIEF-Final phase 3 study data show Spinraza positive results
2017年4月24日 / 中午12点15分 / 7 个月前

BRIEF-Final phase 3 study data show Spinraza positive results

April 24 (Reuters) - Biogen Inc

* Final phase 3 study data show Spinraza(nusinersen) significantly improved motor function in children with later-onset spinal muscular atrophy

* Presymptomatic infants continued to achieve motor milestones generally consistent with normal development in new interim data analysis in study Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below